News

AddToAny

Google+ Facebook Twitter Twitter

High blood platelet count is a predictor

A high platelet count is strongly associated with cancer risk, according to the authors of a new paper.

High blood platelet count is a predictor/ iStock: 158249922

This potentially means that a common blood test could help diagnose cancer earlier, they claim.

The BJGP paper states that raised platelet counts are as good a predictor of getting any cancer as a lump in the breast is for breast cancer.

The team looked at thrombocytosis – a condition in which too many platelets are produced, which is thought to affect about half a million people in the UK over the age of 40.

The researchers compared one-year incidence of cancer between two cohorts: 40,000 patients aged 40 years and over with thrombocytosis, and 10,000 matched patients with a normal platelet count.

They found thrombocytosis is a risk marker of cancer. There was an increase of 11.6% in males and 6.2% of females.

 

Related Articles

girl computer_CREDIT_shutterstock-58872785

Gamification in biomedical science education

Senior Lecturer in Biomedical Science Jen May outlines the successful implementation of scenario-based learning software.

web_blood-testing_credit_istock-1384651794.png

SPONSORED: The power of automated gel-based ID-cards in routine immunohematology workflows

Immuno-haematology assays are pivotal to the carrying out of blood grouping, antibody screening and transfusions, and represent a critically time-dependent stage in the patient management pathway.

Technician holding a blood sample ready for testing with other human medical samples in the background.-Image credit - Science-Photo-Library-f0243823

Machine learning tool to detect cancer via liquid biopsy

US researchers have developed and tested an innovative machine-learning approach that could one day enable the earlier detection of cancer in patients by using smaller blood draws.

multiple myelomatosis-CREDIT-Science Photo Library-m132099

IBMS research grants

We look at the work of Dr Mosavar Farahani who received an IBMS Research Grant in 2023 to help fund her work on disease progression and skeletal complications in multiple myeloma.

Top